These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
978 related articles for article (PubMed ID: 27534744)
21. Screening and In Vitro Evaluation of Potential Plasmodium falciparum Leucyl Aminopeptidase Inhibitors. Chaudhary M; Singh V; Anvikar AR; Sahi S Curr Comput Aided Drug Des; 2016; 12(4):282-293. PubMed ID: 27449897 [TBL] [Abstract][Full Text] [Related]
22. Three-dimensional quantitative structure-activity relationship analysis of a set of Plasmodium falciparum dihydrofolate reductase inhibitors using a pharmacophore generation approach. Parenti MD; Pacchioni S; Ferrari AM; Rastelli G J Med Chem; 2004 Aug; 47(17):4258-67. PubMed ID: 15293997 [TBL] [Abstract][Full Text] [Related]
23. Exploring the structural requirements in multiple chemical scaffolds for the selective inhibition of Plasmodium falciparum calcium-dependent protein kinase-1 (PfCDPK-1) by 3D-pharmacophore modelling, and docking studies. Aher RB; Roy K SAR QSAR Environ Res; 2017 May; 28(5):390-414. PubMed ID: 28562086 [TBL] [Abstract][Full Text] [Related]
24. Pharmacophore modeling of substituted 1,2,4-Trioxanes for quantitative prediction of their antimalarial activity. Gupta AK; Chakroborty S; Srivastava K; Puri SK; Saxena AK J Chem Inf Model; 2010 Aug; 50(8):1510-20. PubMed ID: 20726605 [TBL] [Abstract][Full Text] [Related]
25. In silico identification of promiscuous scaffolds as potential inhibitors of 1-deoxy-d-xylulose 5-phosphate reductoisomerase for treatment of Falciparum malaria. Wadood A; Ghufran M; Hassan SF; Khan H; Azam SS; Rashid U Pharm Biol; 2017 Dec; 55(1):19-32. PubMed ID: 27650666 [TBL] [Abstract][Full Text] [Related]
26. Exploring clotrimazole-based pharmacophore: 3D-QSAR studies and synthesis of novel antiplasmodial agents. Brogi S; Brindisi M; Joshi BP; Sanna Coccone S; Parapini S; Basilico N; Novellino E; Campiani G; Gemma S; Butini S Bioorg Med Chem Lett; 2015 Nov; 25(22):5412-8. PubMed ID: 26428874 [TBL] [Abstract][Full Text] [Related]
27. In vitro efficacy of 7-benzylamino-1-isoquinolinamines against Plasmodium falciparum related to the efficacy of chalcones. Gutteridge CE; Hoffman MM; Bhattacharjee AK; Milhous WK; Gerena L Bioorg Med Chem Lett; 2011 Jan; 21(2):786-9. PubMed ID: 21168330 [TBL] [Abstract][Full Text] [Related]
28. QSAR study on the antimalarial activity of Plasmodium falciparum dihydroorotate dehydrogenase (PfDHODH) inhibitors. Hou X; Chen X; Zhang M; Yan A SAR QSAR Environ Res; 2016; 27(2):101-24. PubMed ID: 26911561 [TBL] [Abstract][Full Text] [Related]
29. Study of the antimalarial activity of 4-aminoquinoline compounds against chloroquine-sensitive and chloroquine-resistant parasite strains. Lawrenson AS; Cooper DL; O'Neill PM; Berry NG J Mol Model; 2018 Aug; 24(9):237. PubMed ID: 30120591 [TBL] [Abstract][Full Text] [Related]
30. Ligand based validated comparative chemometric modeling and pharmacophore mapping of aurone derivatives as antimalarial agents. Adhikari N; Halder AK; Mondal C; Jha T Curr Comput Aided Drug Des; 2013 Sep; 9(3):417-32. PubMed ID: 24010937 [TBL] [Abstract][Full Text] [Related]
31. 3-Iodo-4-aminoquinoline derivative sensitises resistant strains of Plasmodium falciparum to chloroquine. Edaye S; Tazoo D; Bohle DS; Georges E Int J Antimicrob Agents; 2016 Jun; 47(6):482-5. PubMed ID: 27211211 [TBL] [Abstract][Full Text] [Related]
32. Prediction of Novel Anoctamin1 (ANO1) Inhibitors Using 3D-QSAR Pharmacophore Modeling and Molecular Docking. Lee YH; Yi GS Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30336555 [TBL] [Abstract][Full Text] [Related]
33. Drug discovery studies on quinoline-based derivatives as potential antimalarial agents. Sharma R; Patil S; Maurya P SAR QSAR Environ Res; 2014; 25(3):189-203. PubMed ID: 24601770 [TBL] [Abstract][Full Text] [Related]
34. Modelling of human leucyl aminopeptidases for in silico off target binding analysis of potential Plasmodium falciparum leucine aminopeptidase (PfA-M17) specific inhibitors. Sahi S; Raj U; Chaudhary M; Nain V Recent Pat Endocr Metab Immune Drug Discov; 2014; 8(3):191-201. PubMed ID: 25269653 [TBL] [Abstract][Full Text] [Related]
35. Molecular docking and QSAR analyses for understanding the antimalarial activity of some 7-substituted-4-aminoquinoline derivatives. Shibi IG; Aswathy L; Jisha RS; Masand VH; Divyachandran A; Gajbhiye JM Eur J Pharm Sci; 2015 Sep; 77():9-23. PubMed ID: 26006759 [TBL] [Abstract][Full Text] [Related]
36. 4-Aminoquinoline derivatives: Synthesis, in vitro and in vivo antiplasmodial activity against chloroquine-resistant parasites. Singh S; Agarwal D; Sharma K; Sharma M; Nielsen MA; Alifrangis M; Singh AK; Gupta RD; Awasthi SK Eur J Med Chem; 2016 Oct; 122():394-407. PubMed ID: 27394399 [TBL] [Abstract][Full Text] [Related]
37. Combined 3D-QSAR and Molecular Docking Study for Identification of Diverse Natural Products as Potent Pf ENR Inhibitors. Wadhwa P; Saha D; Sharma A Curr Comput Aided Drug Des; 2015; 11(3):245-57. PubMed ID: 26517356 [TBL] [Abstract][Full Text] [Related]
38. Pharmacophore Based 3D-QSAR, Virtual Screening and Docking Studies on Novel Series of HDAC Inhibitors with Thiophen Linker as Anticancer Agents. Patel P; Singh A; Patel VK; Jain DK; Veerasamy R; Rajak H Comb Chem High Throughput Screen; 2016; 19(9):735-751. PubMed ID: 27487787 [TBL] [Abstract][Full Text] [Related]
39. 4-Aminoquinoline-ferrocene Hybrids as Potential Antimalarials. Nqoro X; Aderibigbe BA Recent Pat Antiinfect Drug Discov; 2020; 15(2):157-172. PubMed ID: 32753021 [TBL] [Abstract][Full Text] [Related]
40. Synthesis and evaluation of antimalarial properties of novel 4-aminoquinoline hybrid compounds. Fisher GM; Tanpure RP; Douchez A; Andrews KT; Poulsen SA Chem Biol Drug Des; 2014 Oct; 84(4):462-72. PubMed ID: 24720445 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]